---
figid: PMC4940422__fphar-07-00195-g008
figtitle: Proposed hypothesis for in vivo antifibrotic signaling pathway of serelaxin
  in kidney
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Capra hircus
- Cavia porcellus
- Equus asinus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC4940422
filename: fphar-07-00195-g008.jpg
figlink: /pmc/articles/PMC4940422/figure/F8/
number: F8
caption: Proposed hypothesis for in vivo antifibrotic signaling pathway of serelaxin
  in kidney. Serelaxin mediates its antifibrotic effect via RXFP1/cGMP/cGKI to inhibit
  TGF-β dependent Smad- and ERK-phosphorylation, which subsequently decreases ECM
  accumulation and suppresses profibrotic stimuli; α-SMA, α-smooth muscle actin; cGKI,
  cGMP-dependent protein kinase I; cGMP, cyclic guanosine monophosphate; CTGF, connective
  tissue growth factor; ECM, extracellular matrix; ERK, extracellular-signal regulated
  kinase; GMP, guanosine monophosphate; MMPs, matrix metalloproteinases; PDE5a, phosphodiesterase
  5a; RXFP1, relaxin family peptide receptor 1; Smad, small mothers against decapentaplegic
  protein; TGF-β, transforming growth factor-β.
papertitle: Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase
  I in Renal Antifibrotic Effects of Serelaxin.
reftext: Veronika Wetzl, et al. Front Pharmacol. 2016;7:195.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8574763
figid_alias: PMC4940422__F8
figtype: Figure
redirect_from: /figures/PMC4940422__F8
ndex: c2667673-df1a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4940422__fphar-07-00195-g008.html
  '@type': Dataset
  description: Proposed hypothesis for in vivo antifibrotic signaling pathway of serelaxin
    in kidney. Serelaxin mediates its antifibrotic effect via RXFP1/cGMP/cGKI to inhibit
    TGF-β dependent Smad- and ERK-phosphorylation, which subsequently decreases ECM
    accumulation and suppresses profibrotic stimuli; α-SMA, α-smooth muscle actin;
    cGKI, cGMP-dependent protein kinase I; cGMP, cyclic guanosine monophosphate; CTGF,
    connective tissue growth factor; ECM, extracellular matrix; ERK, extracellular-signal
    regulated kinase; GMP, guanosine monophosphate; MMPs, matrix metalloproteinases;
    PDE5a, phosphodiesterase 5a; RXFP1, relaxin family peptide receptor 1; Smad, small
    mothers against decapentaplegic protein; TGF-β, transforming growth factor-β.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Ltbp1
  - Prkg1
  - Ephb2
  - Mapk1
  - Ccn2
  - Acta2
  - Pde5a
  - Nt5c2
  - Rxfp1
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PRKG1
  - EPHB2
  - MAPK1
  - MAPK3
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - CCN2
  - ACTA1
  - PDE5A
  - NT5C2
  - RXFP1
---
